Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.

Sorry, there's nothing here.

Cite this paper

@article{Eriksson1993ClinicalEO, title={Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.}, author={B I Eriksson and Peter K{\"a}lebo and B I Risberg}, journal={Seminars in thrombosis and hemostasis}, year={1993}, volume={19 Suppl 1}, pages={122-7} }